- The trend backdrop is active with a 7-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
BION
EBS
Week ended 07 Aug 2026
Weekly Investor Report
BB Biotech AG · Healthcare · Biotechnology
Latest close
52.10 CHF
2.0%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 13.9% above the Trend Line and sits at 95.0% of its 52-week range. The latest completed week returned 2.0%, after a 3.0% four-week move. The latest news-sentiment score is 54/100. Near-term considerations: price is close to its 52-week high.
Setup score
69
out of 100
Latest Close
52.10 CHF
7 Aug 2026
1W Return
2.0%
latest completed week
4W Return
3.0%
short-term follow-through
12W Return
16.6%
quarterly tape
Trend Breadth
86.5%
45 of 52 weeks active
Volume Ratio
1.7x
vs 13-week average
- 16 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.0%
Latest completed week; four-week move 3.0%.
Indicator stack
72/86
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
54/100
12 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 13.9% above the Trend Line and sits at 95.0% of its 52-week range. The latest completed week returned 2.0%, after a 3.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6312-week average 0.55
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.63Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1616 reversal markers
No recent accumulation markers. 16 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 3.0% over four weeks, 16.6% over 12 weeks, and 74.0% over one year. The current trend has remained active for 7 consecutive weeks.
Performance by holding period
Active trend streak7 weeks
Active weeks in one year45
Trend breadth86.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.29Latest activity-pressure read.
Pressure change160.3%Four-week change in activity pressure.
Leadership11.23Latest relative-leadership reading.
RS change-13.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 12 relevant articles.
2 positive · 10 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.3%Distance below the 52-week high.
13-week volatility2.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+6.7%Week of 3 Jul.
Worst week-4.0%Week of 24 Apr.
Latest week+2.0%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains9
Flat weeks0
Modest losses12
Sharp losses0
Recent vol2.9%13-week weekly-return volatility.
Base vol2.9%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew2.9% / -2.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCH Healthcare
4-week rank18 / 40
Group average2.0%
Trend breadth52.5%
Trend52.5%active weekly trend signals
MD62.5%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
IndustryCH Biotechnology
4-week rank4 / 11
Group average2.2%
Trend breadth36.4%
Trend36.4%active weekly trend signals
MD36.4%positive activity pressure
RS36.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape69/100
Trend, activity pressure, participation, and risk combine to a 69/100 tape read.
Indicator analysis58/100Latest 12-week confirmation: trend 9/12, activity pressure 5/12, relative leadership 12/12.
Activity pressure 0.63; 16 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 12 relevant articles.
Edison issues report on BB Biotech (BION) Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 52.10 CHF | 2.0% | 45.73 CHF | 36.95 CHF | 1.29 | 11.23 | 479.0K | On |
| 31 Jul 2026 | 51.10 CHF | 0.6% | 45.50 CHF | 36.85 CHF | 1.27 | 11.31 | 635.1K | On |
| 24 Jul 2026 | 50.80 CHF | 2.5% | 45.22 CHF | 36.76 CHF | 1.09 | 11.39 | 548.7K | On |
| 17 Jul 2026 | 49.55 CHF | -2.1% | 44.97 CHF | 36.68 CHF | 0.78 | 9.22 | 274.8K | On |
| 10 Jul 2026 | 50.60 CHF | -0.4% | 44.77 CHF | 36.61 CHF | 0.50 | 12.96 | 391.0K | On |
| 3 Jul 2026 | 50.80 CHF | 6.7% | 44.52 CHF | 36.52 CHF | -0.09 | 12.66 | 79.9K | On |
| 26 Jun 2026 | 47.60 CHF | 4.5% | 44.28 CHF | 36.42 CHF | -0.64 | 8.16 | 76.1K | On |
| 19 Jun 2026 | 45.55 CHF | 4.7% | 44.12 CHF | 36.33 CHF | -0.93 | 7.12 | 205.8K | Off |
| 12 Jun 2026 | 43.50 CHF | 3.1% | 43.95 CHF | 36.26 CHF | -1.05 | 3.39 | 59.2K | Off |
| 5 Jun 2026 | 42.20 CHF | -3.3% | 43.81 CHF | 36.21 CHF | -0.96 | 3.22 | 42.6K | Off |
| 29 May 2026 | 43.65 CHF | -1.1% | 43.68 CHF | 36.18 CHF | -0.70 | 6.08 | 229.9K | On |
| 22 May 2026 | 44.15 CHF | -1.2% | 43.53 CHF | 36.13 CHF | -0.66 | 8.25 | 458.1K | On |
| 15 May 2026 | 44.70 CHF | -0.1% | 43.31 CHF | 36.08 CHF | -0.66 | 12.68 | 253.2K | On |
| 8 May 2026 | 44.75 CHF | 1.4% | 43.04 CHF | 36.04 CHF | -0.56 | 14.66 | 363.4K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.